Literature DB >> 34085018

Concurrent branch retinal artery occlusion in central retinal vein occlusion: 3 cases reports and literature review.

Neha Goel1.   

Abstract

Concurrent branch retinal artery occlusion (BRAO) and central retinal vein occlusion (CRVO) are the infrequently encountered clinical entities, with only a handful of cases elaborated in the literature. This case series describes three patients who presented with a dramatic fundus appearance that led to the diagnosis of unilateral BRAO and CRVO. Hypertension could be identified as a predisposing factor in only one patient. All three patients had relatively good visual acuity at presentation. The role of spectral-domain optical coherence tomography in confirming the simultaneous presence of BRAO is also illustrated. Copyright:
© 2021 Saudi Journal of Ophthalmology.

Entities:  

Keywords:  Branch retinal artery occlusion; central retinal vein occlusion; spectral-domain optical coherence tomography

Year:  2021        PMID: 34085018      PMCID: PMC8081080          DOI: 10.4103/1319-4534.310406

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  10 in total

1.  Branch retinal artery obstruction with simultaneous central retinal vein occlusion.

Authors:  A J Singh
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

2.  Simultaneous central retinal vein and retinal artery branch occlusions in two patients with homocystinaemia.

Authors:  S Ozdek; F Yülek; G Gürelik; B Aydin; B Hasanreisoğlu
Journal:  Eye (Lond)       Date:  2004-09       Impact factor: 3.775

3.  Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion.

Authors:  Ehsan Rahimy; David Sarraf; Michael L Dollin; John D Pitcher; Allen C Ho
Journal:  Am J Ophthalmol       Date:  2014-05-01       Impact factor: 5.258

4.  Combined branch retinal artery and central retinal vein obstruction.

Authors:  J S Duker; M S Cohen; G C Brown; R C Sergott; J A McNamara
Journal:  Retina       Date:  1990       Impact factor: 4.256

5.  Branch retinal artery occlusion and non-ischemic central retinal vein occlusion due to hyperhomocysteinemia in a 14-year-old child.

Authors:  Pearl S Rosenbaum; Sharmila Srinivasan; Joseph R Zelefsky; Martin Mayers; Issac E Moradi
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2010-07-22       Impact factor: 1.402

6.  Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.

Authors:  Masaaki Watanabe; Sumie Ogasawara; Akihiko Takahashi; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Tsutomu Minamino; Hisashi Hidaka; Takahide Nakazawa; Akitaka Shibuya; Wasaburo Koizumi
Journal:  Cutan Ocul Toxicol       Date:  2011-12-16       Impact factor: 1.820

Review 7.  Spectral domain optical coherence tomography findings in eyes with acute ischaemic retinal whitening.

Authors:  Patrick A Coady; Emmett T Cunningham; Robin A Vora; H Richard McDonald; Robert N Johnson; J Michael Jumper; Arthur D Fu; Sara J Haug; Steven L Williams; Brandon J Lujan
Journal:  Br J Ophthalmol       Date:  2014-07-03       Impact factor: 4.638

8.  Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein(a) levels: a case report.

Authors:  A Tavola; S V D'Angelo; F Bandello; R Brancato; M Parlavecchia; O Safa; A D'Angelo
Journal:  Thromb Res       Date:  1995-11-15       Impact factor: 3.944

9.  Dexamethasone implant (ozurdex) in a case with unilateral simultaneous central retinal vein and branch retinal artery occlusion.

Authors:  Taylan Ozturk; Omer Takes; A Osman Saatci
Journal:  Case Rep Ophthalmol       Date:  2015-02-23

10.  Detection of underdiagnosed concurrent branch retinal artery occlusion in a patient with central retinal vein occlusion using spectral domain optical coherence tomography.

Authors:  Anushavan Karapetyan; Pingbo Ouyang; Luo Sheng Tang; Jiexi Zeng; Michele Dominique Li Ying
Journal:  BMC Ophthalmol       Date:  2014-07-12       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.